Efficacy and safety of remibrutinib in CSU: REMIX 1&2 Studies

S. Saini, A.M. Giménez-Arnau, M. Hide, M. Lebwohl, G. Sussman, A. Barron, S. Haemmerle,
I. Hampele, K. Lheritier, E-D Martzloff, A. Zharkov, M. Maurer

Oral Presentation

Long-term safety and efficacy of remibrutinib in patients with CSU

A.M. Giménez-Arnau, J. Tillinghast, V. Jain, S. Haemmerle, K. Lheritier P. Walsh, S. Hugot, M. Wells, A. Zharkov, W. Carr

Oral Presentation

Remibrutinib improves hive severity in patients with CSU

M. Maurer, K. Sitz, A.M. Giménez-Arnau, K. Hayama, V. Jain, K. Lheritier, P. Walsh, S. Haemmerle

Poster

Study design of remibrutinib Phase-3b extension trial in CSU patients

M. Hide, M. Maurer, A. M Giménez-Arnau, S. Saini, M. Lebwohl, G. Sussman, K. Lheritier,
A. Zharkov, L. Wei, E-D. Martzloff, S. Haemmerle

Poster

Remibrutinib achieves early and high response rates in CSU patients

A.M. Giménez-Arnau, M. Maurer, R. Snyder, C-E Ortmann, B. Suryawanshi, I. Nikolaev,
M. Kuruvilla, S. Haemmerle

Poster

Remibrutinib provides fast, clinically important improvement of CSU disease activity

M. Maurer, J. Jacobs, A.M. Giménez-Arnau, S. Savic, C-E. Ortmann, B. Suryawanshi, I. Nikolaev,
S. Haemmerle

Poster

Remibrutinib showed good stability of response in patients with CSU

M. Maurer, J. Tillinghast, V. Jain, A. M. Giménez-Arnau, A. Reich, C-E Ortmann, P. Walsh,
S. Haemmerle

Poster

Remibrutinib improves itch, sleep and activity in patients with CSU

M. Maurer, A.M. Giménez-Arnau, C. Hsu, R. Snyder, L. Clore, V. Jain, K. Lheritier, P. Walsh,
S. Haemmerle, I. Nikolaev

Poster

Remibrutinib showed no impact on blood counts in CSU patients

A.M. Giménez-Arnau, J. Leflein, M. Hide, K. Lheritier, S. Haemmerle, M. Kuruvilla, A. Zharkov

Poster

Remibrutinib showed no impact on serum immunoglobulin in CSU patients

A.M. Giménez-Arnau, W. Carr, K. Lheritier, S. Haemmerle, A. Zharkov, S. Dahale, K. Hayama

Poster

Remibrutinib improves CSU symptoms irrespective of previous anti-IgE treatment

M. Maurer, A. Greiner, S. Guduri, J. Leflein, S. Haemmerle, K. Lheritier, P. Walsh, I. Nikolaev,
A.M, Giménez-Arnau

Poster

Pooled safety analysis of remibrutinib in inflammatory immune-mediated diseases

M. Hide, S. Saini, M. Maurer, A.M. Giménez-Arnau, G. Sussman, S. Haemmerle, N. Barbier,
A. Zharkov

Poster

Remibrutinib improves CSU in patients regardless of prior oral treatments

A.M. Giménez-Arnau, L. Clore, M. Maurer, C-E. Ortmann, B. Suryawanshi, M. Kuruvilla,
S. Haemmerle

Poster

Systemic manifestations during symptomatic episodes in CSU: Urticaria Voices Study

J.A. Bernstein, T.A. Winders, T. Raftery, P. Saraswat, J. McCarthy, M. Kuruvilla, M-M Balp, K. Weller

Poster

Urticaria Voices: Patient-reported outcome measures for monitoring CSU in clinic

J.A. Bernstein, P. Laires, M-M. Balp, P. Saraswat, T. Raftery, J. McCarthy, M. Dricu, T.A. Winders,
K. Weller

Poster

Antihistamine treatment patterns and patient reported control In CSU

K. Weller, J.A Bernstein, M-M. Balp, J. McCarthy, M. Kuruvilla, P. Saraswat, T. Raftery, T.A. Winders

Poster

Patients’ perspective on negative impact of CSU on their lives

K. Weller, P. Laires, M-M Balp, T. Raftery, P. Saraswat, J. McCarthy, M. Dricu, T.A. Winders,
J.A. Bernstein

Poster

Remission and relapse profiles in chronic urticaria: PREDICT-CU study

A. Marsland, M-M.Balp, I. Pivneva, A. Danyliv, K. Chen, T. Cornwall, J. Signorovitch, D. Patil,
R. Kohli, T. Severin, W. Soong

Poster